Navigation Links
Researcher working on destruction of chemical weapons
Date:12/23/2008

COLLEGE STATION, Sept. 24, 2008 America's war on terror includes fighting the dark side of deadly chemical agents, and Texas A&M University chemist Dr. Frank Raushel is helping with the fight by developing an enzyme that might neutralize one such chemical agent, the organophosphates.

Synthetic organophosphates started their journey as insecticides in the 1930s but soon made their way into the dangerous alleys of chemical warfare during World War II. Raushel, who has been working on detoxification of organophosphates for nearly 10 years, says that the toxic properties of the organophosphate nerve agents are a serious threat to the health and well being of civilized societies.

Although outlawed by several international treaties, some countries have used chemical agents during times of war. In 1988, the Iraqi Kurdish village of Halabja was exposed to multiple chemical agents, killing about 5,000 of the town's 50,000 residents. After the incident, traces of mustard gas and the organophosphates sarin, tabun and VX were discovered.

Raushel, the Davidson Professor of Science at Texas A&M, has been awarded a four-year grant of $1.2 million by the National Institutes of Health to carry out his work on organophosphates.

Organophosphates are neurotoxins they attack the nervous system by blocking the function of the enzyme acetylcholine esterase, which carries nerve signals. When organs such as the lungs do not receive appropriate nerve signals, control is lost over respiratory muscles, and it usually results in death by asphyxiation. Today, some classes of organophosphates are used as insecticides while others have been categorized as chemical weapons.

Researchers have discovered a bacterial enzyme, phosphotriesterase, which can recognize and destroy the toxicity of a broad spectrum of organophosphate nerve agents. What Raushel aims to do is design and characterize bacterial phosphotriesterases that are better at detecting, destroying and detoxi
'/>"/>

Contact: Dr. Frank Raushel
raushel@mail.chem.tamu.edu
979-845-3373
Texas A&M University
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Clemson researchers advance nanoscale electromechanical sensors
2. Purdue researcher invents molecule that stops SARS
3. Duke researchers coax bright white light from unexpected source
4. Pitt researchers create nontoxic clean-up method for potentially toxic nano materials
5. USC researchers print dense lattice of transparent nanotube transistors on flexible base
6. New Online Video Features Brazilian Researcher Elbio Rech
7. J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology
8. Virginia Tech researchers discover how mosquitoes avoid succumbing to viruses they transmit
9. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
10. Self-powered devices possible, says Texas A&M researcher
11. 2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Canna can: Ornamental eliminates pollutants from stormwater runoff 2New engineering institute to modify, develop technology for the global poor 2New engineering institute to modify, develop technology for the global poor 3Berkeley Lab researchers participate in Homeland Security study of subway airflow 2CIGNA Awarded State of Arizona Health Care Contract 54926 1CIGNA Awarded State of Arizona Health Care Contract 54926 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 1Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 3Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 4Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 5Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 6Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 7Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 8Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 9Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 1Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 2Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 3